Botulinum a Toxin Treatment for Blepharospasm and Meige Syndrome : Report of 100 Patients

Journal of the Medical Association of Thailand

Volumn 80, Issue 1, 1997, Pages

  Poungvarin, Niphon ^a   Devahastin, Vorapun ^a   Chaisevikul, Rungsun ^a   Prayoonwiwat, Naraporn ^a   Viriyavejakul, Adulya ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; CLINICAL TRIAL; DRUG EFFICACY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEIGE DISEASE; PTOSIS; VISUAL DISORDER;

ADOLESCENT; ADULT; AGED; BLEPHAROSPASM; BOTULINUM TOXIN TYPE A; CHILD; FEMALE; HUMANS; MALE; MEIGE SYNDROME; MIDDLE AGED; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 2542600854     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Grandas F, Elston JS, Quinn N, Marsden CD. Blepharospasm: A review of 264 patients. J Neurol Neurosurg Psychiat 1988; 51: 767-72.
2. Elston JS, Marsden CD. The significance of ophthalmological symptoms in idiopathic blepharospasm. Eye 1988; 2: 435-9.
3. Marsden CD. Blepharospasm-oromandibular dystonia (Brueghel's syndrome). A variant of adult onset torsion dystonia. J Neurol Neurosurg Psychiat 1976; 39: 1204-9.
4. Elston JS. A New variant of blepharospasm. J Neurol Neurosurg Psychiat 1992; 55: 369-71.
5. Berardelli A, Rothwell J, Day BL, Marsden CD. The pathophysiology of blepharospasm and oromandibular dystonia. Brain 1985; 108: 593-608.
6. Lueck CJ, Tanyeri S, Crawford TJ, Elsto JS, Kennard C. Saccadic eye movements in essential blepharospasm. J Neurol 1990; 237: 226-9.
7. Kraft SP, Lang AE. Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations. Can J Neurol Sci 1988; 15: 276-80.
8. Cohen DA, Savino PJ, Stern MB, Hurtig HI. Botulinum injection for blepharospasm: A review and report of 75 patients. Clin Neuropharmacol 1986; 9: 415-29.
9. Engstrom PF, Arnoult JB, Mazlow ML, et al. Effectiveness of botulinum toxin therapy for essential blepharospasm. Ophthalmology 1987; 94: 971-5.
10. Dutton JJ, Buckley EG. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 1988; 95: 1529-34.
11. Elston JS. Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections. Br J Ophthalmol 1987; 71: 664-8.
12. Taylor JDN, Kraft SP, Kazdan MS, et al. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: A Canadian multicentre study. Can J Ophthalmol 1991; 26: 133-8.
13. Mauriello JA Jr, Coniaris H, Haupt EJ. Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias. Ophthalmolgy 1987; 94: 976-9.
14. Gundersen CB. The effects of E toxin on the synthesis, storage and release of acetylcholine. Prog Neurobiol 1980; 14: 99-119.
15. Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Annu Rev Pharmacol Toxicol 1986; 26: 427-53.
16. 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J Cell Biol 1986; 103: 521-34.
17. 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-medicated endocytosis. J Cell Biol 1986; 103: 535-44.
18. Duchen LW, Strich SJ, The effects of botulinum toxin on the pattern of innervation of skeletal muscle in the mouse. Q J Exp Physiol 1968; 53: 84-9.
19. Angaut PD, Molgo J, Comella JX, et al. Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: Morphological and electrophysiological features. Neuroscience 1990; 47: 799-08.
20. Diaz J, Molgo J, Pecot-Dechavassine M. Sprouting of frog motor nerve terminals after longterm paralysis by botulinum type A toxin. Neurosci Lett 1989; 96: 127-32.
21. Holds JB, Alderson K, Fogg SG, Anderson RL. Motor nerve sprouting in human orbicularis muscle following botulinum A injection. Invest Ophthalmol Vis Res 1990; 31: 964-7.
22. Poungvarin N, Viriyavejakul A. Two hundred and fifty patients with hemifacial spasm treated with botulinum toxin injection. J Med Assoc Thai 1992; 75: 199-03.
23. Poungvarin N. Writer's cramp: The experience with botulinum toxin injections in 25 patients. J Med Assoc Thai 1991; 74: 239-47.
24. Poungvarin N, Viriyavejakul A. Botulinum A toxin treatment in spasmodic torticollis: Report of 56 patients. J Med Assoc Thai 1994; 77: 464-70.
25. Poungvarin N, Devahastin V, Viriyavejakul A. Treatment of various movement disorders with botulinum A toxin injection: An experience of 900 patients. J Med Assoc Thai 1995; 78: 281-8.
26. Poungvarin N, Viriyavejakul A, Komoltri C. Placebo-controlled double-blind cross-over study of botulinum A toxin in hemifacial spasm. Parkinsonism and Related Disorders 1995; 1: 85-8.
27. Nutt JG, Hammerstad JP, DeGarmo P, Carter J. Cranial dystonia: double-blind cross-over study of anticholinergics. Neurology 1984; 34: 215-7.
28. Lang AE. High dose anticholinergic therapy in adult dystonia. Can J Neurol Sci 1986; 13: 42-6.
29. Talbot JF, Gregor Z, Bird AC. The surgical management of essential blepharospasm. In: Marsden CD, Fahn S, eds. Movement Disorders. London: Butterworths, 1982: 322-9.
30. McCord CD, Coles WH, Shore JW, Spector R, Putnam JR. Treatment of essential blepharospasm. I. Comparison of facial nerve avulsion and eyebrow-eyelid muscle stripping procedures. Arch Ophthalmol 1984; 102: 266-8.
31. Gillum WN, Anderson RL. Blepharospasm surgery. An anatomical approach. Arch Ophthalmol 1981; 99: 1056-62.
32. McCord CD, Shore J, Putnam JR. Treatment of essential blepharospasm. II. A modification of exposure for the muscle stripping technique. Arch Ophthalmol 1984; 102: 269-73.
33. Battista AF. Surgical approach to blepharospasm: nerve thermolysis. In: Marsden CD, Fahn S, eds. Movement Disorders. London: Butterworths, 1982: 319-21.
34. Dutton JJ. Acute and chronic effects of botulinum toxin in the management of blepharospasm. In: Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, Inc., 1994: 199-09.